Skip to main content
Caplight Logo









ZWI Therapeutics

ZWI Therapeutics

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://zwitx.com

Last Round

Series A

Jan 24, 2024

Total Funding Raised

$10M

Company Overview

ZWI Therapeutics is a biotechnology company that develops protein therapeutics using proprietary polycarboxybetaine polymer technology to enhance safety and efficacy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

zwitterionic polymerdrug deliverybiologicspolycarboxybetainePEG alternativeprotein therapeuticsimmunogenicity reductionpharmacokineticsbiotech licensingbiocompatible polymersprotein conjugationnext-gen biologicsdrug delivery platformbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZWI Therapeutics Comparables

Compare ZWI Therapeutics with similar companies based on industry and business-model similarity.

ZWI Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sanofi
71%
Nektar Therapeutics
71%
Serina Therapeutics Inc
69%

ZWI Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 24, 2024

ZWI Therapeutics Investors

Notable investors and investment history

ZWI Therapeutics investors
InvestorRounds
Co-Win VenturesSeries A
Sherpa Healthcare PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 24, 2024

    $10M round with Co-Win Ventures and Sherpa Healthcare Partners.

ZWI Therapeutics Filings

Explore SEC and related filing metadata, where available.

ZWI Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZWI Therapeutics's valuation, stock price, and market status.

Is ZWI Therapeutics a public or private company?

ZWI Therapeutics is a private company.

What is the current stock price of ZWI Therapeutics?

ZWI Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is ZWI Therapeutics worth (valuation)?

Valuation information for ZWI Therapeutics is not publicly available.

Can I buy ZWI Therapeutics stock?

ZWI Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZWI Therapeutics's last funding round?

ZWI Therapeutics's most recent funding round was Series A on January 24, 2024.

Who are the main investors in ZWI Therapeutics?

Key investors in ZWI Therapeutics include Co-Win Ventures, Sherpa Healthcare Partners.

Will ZWI Therapeutics IPO soon?

No public IPO plans have been announced for ZWI Therapeutics.

How can I track ZWI Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZWI Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWatertown, Massachusetts
Year Founded2020
Last FundingJan 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?